EFFICACY OF ERLOTINIB FOR CNS RELAPSE AFTER GEFITINIB TREATMENT IN NON SMALL CELL LUNG CANCER PATIENTS

被引：0
|
作者：
Yanagitani, N. [1 ]
Sakatani, T. [1 ]
Saito, R. [1 ]
Tanaka, H. [1 ]
Kaburaki, K. [1 ]
Kudo, K. [1 ]
Ohyanagi, F. [1 ]
Horiike, A. [1 ]
Horai, T. [1 ]
Nishio, M. [1 ]
机构：
[1] Japanese Fdn Canc Res, Thorac Oncol Ctr, Canc Inst Hosp, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：155 / 156
页数：2
相关论文
共 50 条
  • [1] Efficacy of erlotinib for CNS relapse in non-small cell lung cancer patients after gefitinib treatment
    Yanagitani, N.
    Tanaka, H.
    Miyauchi, E.
    Motokawa, I.
    Kudo, K.
    Ohyanagi, F.
    Horiike, A.
    Horai, T.
    Nishio, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Efficacy and dose of afatinib in patients with non-small cell lung cancer after failure of prior gefitinib or erlotinib treatment
    Choi, Hayoung
    Lee, Jae-Kyeong
    Oh, Hyung-Joo
    Kim, Min-Seok
    Kho, Bo Gun
    Park, Cheol Kyu
    Oh, In-Jae
    Kim, Young-Chul
    THORACIC CANCER, 2021, 12 (10) : 1598 - 1604
  • [3] EFFICACY OF ERLOTINIB AFTER THE FAILURE OF GEFITINIB IN PATIENTS WITH ADVANCED OR METASTASIS NON-SMALL CELL LUNG CANCER
    Wang Yan
    Li Junling
    Wang Ziping
    Guo Jihong
    Yu Shufei
    Hao Xuezhi
    Hu Xingsheng
    Wang Bin
    Zhang Xiangru
    Shi Yuankai
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1238 - S1239
  • [4] Treatment of Non-Small-Cell Lung Cancer with Erlotinib or Gefitinib
    Cataldo, Vince D.
    Gibbons, Don L.
    Perez-Soler, Roman
    Quintas-Cardama, Alfonso
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (10): : 947 - 955
  • [5] Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment
    Song Zheng-bo
    Yu Yong-feng
    Chen Zhi-wei
    Lu Shun
    CHINESE MEDICAL JOURNAL, 2011, 124 (15) : 2279 - 2283
  • [6] Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment
    SONG ZhengboYU YongfengCHEN Zhiwei and LU Shun Shanghai Lung Tumor Clinical Medical CenterChest Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China
    中华医学杂志(英文版), 2011, (15) : 2279 - 2283
  • [7] Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure
    Cho, Kyoung Min
    Keam, Bhumsuk
    Kim, Tae Min
    Lee, Se-Hoon
    Kim, Dong-Wan
    Heo, Dae Seog
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2015, 30 (06): : 891 - 898
  • [8] Gefitinib or Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer
    Shao, Yu-Yun
    Lin, Chia-Chi
    Yang, Chih-Hsin
    DISCOVERY MEDICINE, 2010, 9 (49) : 538 - 545
  • [9] Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer
    Kaye, Frederic J.
    Jantz, Michael A.
    Dallas, Jennifer
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2367 - 2367
  • [10] Evaluation of erlotinib treatment after gefitinib failure in Japanese recurrent non-small cell lung cancer patients
    Hata, A.
    Nanjo, S.
    Kaji, R.
    Hujita, S.
    Katakami, N.
    Nishimura, T.
    Ishihara, K.
    Yoshioka, H.
    Hayashi, H.
    Ishida, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345